Search Results

You are looking at 131 - 140 of 614 items for :

  • "surveillance" x
Clear All
Full access

Mary Ann Morgan and Crystal S. Denlinger

-management; (2) surveillance for cancer spread, recurrence, or second cancers, along with monitoring for late effects, including psychological consequences; (3) interventions for these effects; and (4) coordination between the oncology providers and PCPs. 5

Full access

Christina A. Minami and Karl Y. Bilimoria

present, with information from more than 1,500 CoC-accredited hospitals throughout the United States and Puerto Rico. The NCDB is a facility-based clinical surveillance resource that is also meant to be used in quality improvement (QI), allowing hospitals

Full access

Randall W. Burt, James S. Barthel, Kelli Bullard Dunn, Donald S. David, Ernesto Drelichman, James M. Ford, Francis M. Giardiello, Stephen B. Gruber, Amy L. Halverson, Stanley R. Hamilton, Mohammad K. Ismail, Kory Jasperson, Audrey J. Lazenby, Patrick M. Lynch, Edward W. Martin Jr., Robert J. Mayer, Reid M. Ness, Dawn Provenzale, M. Sambasiva Rao, Moshe Shike, Gideon Steinbach, Jonathan P. Terdiman and David Weinberg

reduction persists after colonoscopy. They compared incidence of CRC among patients in the surveillance cohort with that in the general population. A negative colonoscopy was associated with a standardized incidence ratio of 0.28 (95% CI, 0.09–0.65) at 10

Full access

of capecitabine + oxaliplatin was added as an option in adjuvant therapy with a category 2A designation. Footnote “j” was clarified by adding “exclusive of those cancers that are MSI-H” to grade 3-4. Surveillance Chest

Full access

Amit G. Singal, Akbar K. Waljee, Nishant Patel, Emerson Y. Chen, Jasmin A. Tiro, Jorge A. Marrero and Adam C. Yopp

only available for patients diagnosed at an early stage. 2 Surveillance at 6-month intervals is recommended in patients with cirrhosis to detect HCC at an early stage. 3 Despite the availability of efficacious surveillance tests, only 40% of patients

Full access

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Clair Beard, Sam Bhayani, Graeme B. Bolger, Sam S. Chang, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Shilpa Gupta, Steven L. Hancock, Jenny J. Kim, Timothy M. Kuzel, Elaine T. Lam, Clayton Lau, Ellis G. Levine, Daniel W. Lin, M. Dror Michaelson, Thomas Olencki, Roberto Pili, Elizabeth R. Plimack, Edward N. Rampersaud, Bruce G. Redman, Charles J. Ryan, Joel Sheinfeld, Brian Shuch, Kanishka Sircar, Brad Somer, Richard B. Wilder, Mary Dwyer and Rashmi Kumar

Guidelines provide a framework for follow-up of patients undergoing surveillance of a small renal mass, those who underwent surgery or ablative therapy of a primary RCC, and those undergoing NCCN Guidelines Insights : Kidney Cancer, Version 3

Full access

Diana I. Brixner, Gary M. Oderda, Nancy A. Nickman, Roy Beveridge and James A. Jorgenson

: http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.561v1 . Accessed January 2006 . 9. Weir HK Thun MJ Hankey BF . Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer

Full access

MD Wang Jue MD 6 2009 7 7 6 6 618 618 630 630 10.6004/jnccn.2009.0043 Optimal Management of Localized Renal Cell Carcinoma: Surgery, Ablation, or Active Surveillance Chen David Y. T. MD Uzzo Robert G. MD Robinson Kerrin G

Full access

Thomas A. D’Amico, Lindsey A.M. Bandini, Alan Balch, Al B. Benson III, Stephen B. Edge, C. Lyn Fitzgerald, Robert J. Green, Wui-Jin Koh, Michael Kolodziej, Shaji Kumar, Neal J. Meropol, James L. Mohler, David Pfister, Ronald S. Walters and Robert W. Carlson

also may impact patients with fewer involved nodes, but controversy remains, and therefore patients with 1 to 3 positive axially nodes were not included in this quality measure. Posttreatment Surveillance Markers of tumor in the serum or blood may help

Full access

Mina Shenouda, Vivek Yadala, Jennifer Dotson and Toni Pacioles

PC pts, including 5.2% of pts without a family history of PC. Relatives of pts with Lynch syndrome or genetically mutated PC could then be offered genetic testing/ counseling, and where indicated, additional surveillance for various cancers based upon